First-line therapy for non-transplant eligible patients with multiple myeloma: direct and adjusted indirect comparison of treatment regimens on the existing market in Germany Kathrin KuhrDaniel WirthMartin Hellmich Review 16 December 2015 Pages: 257 - 265
No effect on QT intervals of mipomersen, a 2′-O-methoxyethyl modified antisense oligonucleotide targeting ApoB-100 mRNA, in a phase I dose escalation placebo-controlled study, and confirmed by a thorough QT (tQT) study, in healthy subjects Rosie Z. YuRudy GunawanYanfeng Wang Clinical Trial 09 December 2015 Pages: 267 - 275
Impact of CYP3A5 polymorphism on trough concentrations and outcomes of tacrolimus minimization during the early period after kidney transplantation Khemjira YaowakulpatanaSomratai VadcharavivadChagriya Kitiyakara Pharmacogenetics 04 December 2015 Pages: 277 - 283
Therapeutic drug monitoring of second-generation antipsychotics in pediatric patients: an observational study in real-life settings Marco PozziDario CattaneoEmilio Clementi Pharmacokinetics and Disposition 28 November 2015 Pages: 285 - 293
Effect of commercial Rhodiola rosea on CYP enzyme activity in humans Ole Kristian ThuOlav SpigsetBent Hellum Pharmacokinetics and Disposition 28 November 2015 Pages: 295 - 300
A longitudinal comparison of drug use among 10-year-old children and 15-year-old adolescents from the German GINIplus and LISAplus birth cohorts Salvatore ItaliaIrene BrüskeSilke B. Wolfenstetter Original Article Open access 19 November 2015 Pages: 301 - 310
Gender differences in statin prescription rates, adequacy of dosing, and association of statin therapy with outcome after heart failure hospitalization: a retrospective analysis in a community setting Piercarlo BalloDaniela BalziAlfredo Zuppiroli Pharmacoepidemiology and Prescription 19 November 2015 Pages: 311 - 319
Quality of assessment and counselling offered by community pharmacists and medication sale without prescription to patients presenting with acute cardiac symptoms: a simulated client study Tarek Seifaw KashourAbdulaziz JouryLukman Thalib Pharmacoepidemiology and Prescription 23 November 2015 Pages: 321 - 328
Comparison of treatment persistence with different oral anticoagulants in patients with atrial fibrillation Tomas ForslundBjörn WettermarkPaul Hjemdahl Pharmacoepidemiology and Prescription 27 November 2015 Pages: 329 - 338
Medicine use and disease control among adolescents with asthma Elin DahlénBjörn WettermarkInger Kull Pharmacoepidemiology and Prescription 15 December 2015 Pages: 339 - 347
Influence of baseline low-density lipoprotein cholesterol values on statin therapy persistence Anna CitarellaMarie LinderMorten Andersen Pharmacoepidemiology and Prescription 16 December 2015 Pages: 349 - 357
Prescription of antibacterial agents for acute upper respiratory tract infections in Beijing, 2010–2012 Yiqun WuChao YangYonghua Hu Pharmacoepidemiology and Prescription Open access 26 December 2015 Pages: 359 - 364
Suspected pharmacokinetic interaction between raltegravir and the 3D regimen of ombitasvir, dasabuvir and paritaprevir/ritonavir in an HIV-HCV liver transplant recipient Dario CattaneoSalvatore SollimaCristina Gervasoni Letter to the Editors 12 September 2015 Pages: 365 - 367
Gastric emptying and acetaminophen: lessons learnt from the several co-administered drugs on the experimental design Nuggehally R. Srinivas Letter to the Editors 08 September 2015 Pages: 369 - 371
Cinacalcet-associated severe hypocalcemia resulting in torsades de pointes and cardiac arrest: a case for caution Tessa NovickBlaithin A. McMahonBernard G. Jaar Letter to the Editors 01 December 2015 Pages: 373 - 375
Concomitant administration of rifampicin and oxcarbazepine results in a significant decrease of the active MHD metabolite of oxcarbazepine Ali SigaroudiGerd A. Kullak-UblickStefan Weiler Letter to the Editors 03 December 2015 Pages: 377 - 378